Details of the Drug

General Information of Drug (ID: DMO7RO5)

• Drug Name: STP705

Indication

Disease Entry	ICD 11	Status	REF
Basal cell carcinoma	2C32	Phase 2	[1]
Hypertrophic scars	EE60	Phase 1/2	[2]

• Cross-matching ID: TTD ID: D0E9XR
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT04669808) Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma. U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)